Keros Therapeutics (KROS) Free Cash Flow Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | 44.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.10% |
| Sep 30, 2025 | 105.76% |
| Jun 30, 2025 | 26.69% |
| Mar 31, 2025 | 458.58% |
| Dec 31, 2024 | -78.08% |
| Sep 30, 2024 | 1.87% |
| Jun 30, 2024 | -23.21% |
| Mar 31, 2024 | -30.75% |
| Dec 31, 2023 | -14.68% |
| Sep 30, 2023 | -32.85% |
| Jun 30, 2023 | -42.87% |
| Mar 31, 2023 | -2,162.62% |
| Dec 31, 2022 | -14.94% |
| Sep 30, 2022 | -68.59% |
| Jun 30, 2022 | -22.72% |
| Mar 31, 2022 | 85.59% |
| Dec 31, 2021 | -144.99% |
| Sep 30, 2021 | -33.99% |
| Jun 30, 2021 | -84.40% |
| Mar 31, 2021 | -26.63% |
| Dec 31, 2020 | -45.96% |
| Sep 30, 2020 | -258.45% |
| Jun 30, 2020 | -91.33% |
| Mar 31, 2020 | -230.12% |